Nektar Therapeutics Inventory, Raw Materials, Net of Reserves
Nektar Therapeutics (NKTR) had Inventory, Raw Materials, Net of Reserves of $0 as of 2024-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative
us-gaap:InventoryRawMaterialsNetOfReserves · last filed 2025-03-14
- 2024-12-31: Inventory, Raw Materials, Net of Reserves $0.00.
- 2024-09-30: Inventory, Raw Materials, Net of Reserves $0.00.
- 2024-06-30: Inventory, Raw Materials, Net of Reserves $1.72M.
- 2024-03-31: Inventory, Raw Materials, Net of Reserves $1.94M.
| Period end | Inventory, Raw Materials, Net of Reserves |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-14 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 |
| 2024-06-30 | $1.72M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $1.94M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.86M 10-K · filed 2025-03-14 |
| 2023-09-30 | $1.92M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $2.04M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.23M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $2.58M 10-K · filed 2024-03-05 |
| 2022-09-30 | $2.05M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $2.10M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $2.08M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $3.17M 10-K · filed 2023-02-28 |
| 2021-09-30 | $1.74M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $2.00M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $1.92M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $2.42M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.39M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $1.68M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $1.20M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $1.67M 10-K · filed 2021-02-26 |
| 2019-09-30 | $1.59M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.76M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $1.69M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.85M 10-K · filed 2020-02-28 |
| 2018-09-30 | $1.80M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.81M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.74M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $1.80M 10-K · filed 2019-03-01 |
| 2017-09-30 | $1.75M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.54M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $1.88M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $2.06M 10-K · filed 2018-03-01 |
| 2016-09-30 | $2.39M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $2.63M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $3.05M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $3.24M 10-K · filed 2017-03-01 |
| 2015-09-30 | $1.78M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $2.39M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $2.40M 10-Q · filed 2015-05-01 |
| 2014-12-31 | $2.20M 10-K · filed 2016-02-29 |
| 2014-09-30 | $1.73M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $1.72M 10-Q · filed 2014-08-01 |
| 2013-12-31 | $3.95M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |